Is ABT or TMO cheaper?

On trailing earnings, ABT is cheaper: ABT trades at a 24.56 P/E and TMO at 25.80.

Which has grown faster, ABT or TMO?

Over the past five years, TMO grew revenue faster — ABT at a 3.87% CAGR versus TMO at 6.68%.

Does ABT or TMO pay a bigger dividend?

ABT yields 2.77% and TMO yields 0.28% based on trailing dividends and the latest price.

Is ABT or TMO more profitable?

TMO runs the higher net margin — ABT at 13.91% versus TMO at 15.18%.

Which has been the better investment, ABT or TMO?

Over the past 10-year, TMO delivered the higher annualized total return — ABT at 10.72% versus TMO at 12.26%. Past performance doesn't predict future results.

Abbott Laboratories (ABT) vs Thermo Fisher Scientific Inc. (TMO)

ABT leads on 12 of 17 compared metrics.

A side-by-side comparison of Abbott Laboratories and Thermo Fisher Scientific Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 13, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

Thermo Fisher Scientific Inc.

$174.42B

$469.34Healthcare

Total return — ABT vs TMO

growth of $100 · last 30y

ABT +804.4%TMO +1154.9%TMO compounded faster

ABT TMO

ABT vs TMO: by the numbers

•TMO is the larger company ($174.42B vs $153.59B market cap).
•ABT trades at the lower earnings multiple (24.56 vs 25.80 P/E).
•TMO converts more revenue to profit (15.18% vs 13.91% net margin).
•TMO grew revenue faster over the past five years (6.68% vs 3.87% CAGR).
•ABT pays the higher dividend yield (2.77% vs 0.28%).

Which is better, ABT or TMO?

Metric tally: ABT 12 · TMO 5

It depends on what you're optimizing for:

ValueABT(lower P/E)

GrowthTMO(faster 5Y revenue CAGR)

IncomeABT(higher dividend yield)

QualityABT(higher ROIC)

Valuation

Metric	ABT	TMO
P/E ratio	24.56●	25.80
Forward P/E	14.56●	17.26
P/S ratio	3.41●	3.87
P/B ratio	2.96●	3.37
PEG ratio	2.99●	4.51
EV / EBITDA	17.30●	19.26
FCF yield	4.79%●	3.86%

Profitability

Metric	ABT	TMO
Gross margin	56.38%●	39.41%
Operating margin	18.17%●	17.76%
Net margin	13.91%	15.18%●
ROE	12.06%	13.21%●
ROIC	8.43%●	7.58%

Dividends

Metric	ABT	TMO
Dividend yield	2.77%●	0.28%
Payout ratio	65.24%	7.48%

Growth (annualized)

Metric	ABT	TMO
Revenue CAGR (5Y)	3.87%	6.68%●
EPS CAGR (5Y)	8.22%●	1.99%
FCF CAGR (5Y)	-0.61%	-0.19%●
Total return CAGR (5Y)	-2.49%	0.45%●

Frequently asked

Which is better, ABT or TMO?: It depends on your goal. value: ABT (lower P/E); growth: TMO (faster 5Y revenue CAGR); income: ABT (higher dividend yield); quality: ABT (higher ROIC). Across all compared metrics, ABT leads 12 to 5.
Is ABT or TMO cheaper?: On trailing earnings, ABT is cheaper: ABT trades at a 24.56 P/E and TMO at 25.80.
Which has grown faster, ABT or TMO?: Over the past five years, TMO grew revenue faster — ABT at a 3.87% CAGR versus TMO at 6.68%.
Does ABT or TMO pay a bigger dividend?: ABT yields 2.77% and TMO yields 0.28% based on trailing dividends and the latest price.
Is ABT or TMO more profitable?: TMO runs the higher net margin — ABT at 13.91% versus TMO at 15.18%.
Which has been the better investment, ABT or TMO?: Over the past 10-year, TMO delivered the higher annualized total return — ABT at 10.72% versus TMO at 12.26%. Past performance doesn't predict future results.

Go deeper

Full ABT analysis Full TMO analysis Interactive comparison tool

Dig into the metrics

Abbott Laboratories P/E ratio Thermo Fisher Scientific P/E ratio Abbott Laboratories dividend yield Thermo Fisher Scientific dividend yield Abbott Laboratories ROE Thermo Fisher Scientific ROE Abbott Laboratories operating margin Thermo Fisher Scientific operating margin Abbott Laboratories revenue growth Thermo Fisher Scientific revenue growth Abbott Laboratories free cash flow Thermo Fisher Scientific free cash flow

Abbott Laboratories & Thermo Fisher Scientific appear in these rankings

Highest Dividend Yield Stocks Dividend Aristocrats Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 13, 2026.